Autoimplantation therapy for the management of extensive molluscumcontagiosum: a novel treatment approach

Kalpana Gupta, Anurag Bareth, Nidheesh Agarwal


Background: Molluscumcontagiosum (MC) is a common cutaneous viral infection which usually affects children. Inspite of the multiple treatment options such as curettage, expression, electrodessication and different topical agents, in some cases lesions become extensive and persist for more than 3 to 4 years. The role of immunomodulatory therapy in management of MC has been well documented. Autoimplantation has emerged as a useful immunomodulatory therapy for warts. The objective of the study is to assess the efficacy and safety of autoimplantation in treatment of extensive MC.

Methods: Patients of   either sex having more than six MC lesions were included. Molluscum body removed, crushed & implanted in a small dermal pocket as described in cases of warts. Patients were evaluated at four weeks, 12 weeks & subsequent 24 weeks.

Results: Twenty two patients completed the study. Complete clearance of the MC was seen in 17 (77.2%) patients, 2 (9.1%) had no response, 1 (4.5%) had partial remission & 2 patients (9.1%) showed recurrence.

Conclusions: Autoimplantation may be effective& alternative modalities for extensive MC. However, more randomized controlled trial for automplantation therapy in extensive MC need to be warranted.


Mollouscum contagiosum, Autoimplantation

Full Text:



Nandhini G, Rajkumar K, Kanth SK, Nataraj P, Ananthakrishnan P, Arunachalam M. Molluscumcontagiosum in a 12 year old child-report of a case and review of literature. J Int Oral Health. 2015;7(1):63-6.

Bhatia AC. Mollouscum cntagiosum: background, etiology, epidemiology. Northwestern University department of dermatology, Feinberg School of medicine; 2011. Available at: Accessed on 1 April 2016.

Van der Wooden JC, Van der Sande R, Van Suijlekom-Smit LW, Berger M, Butler CC, Koning S. Intervention for cutaneous molluscumcotagiosum. Cochrane Database Sys Rev. 2009;(4):CD004767.

Shivakumar V, Okade R, Rajkumar V. Autoimplantation therapy for multiple warts. Indian J Dermatol Venereol Leprol. 2009;75:593-5.

Sharquie KE, Hameed AF, Abdulwahhab WS. Pathogenesis of molluscumcontagiosum: a new concept for the spontaneous involution of the disease. Our Dermatol Online. 2015;6(3):265-9.

Nguyen HP, Franz E, Stiegel KR, Hsu S, Tyring SK. Treatment of molluscumcontagiosum in adult, pediatric, and immune deficient populations. J Cutan Med Surg. 2014;18(5):299-306.

Hammes S, Greve B, Raulin C. Mollouscumcotagiosum: Treatment with pulsed dye laser. Hautarzt. 2001;52(1):38-42.

Syed TA, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscumcontagiosum in males. A placebo-controlled, double-blind study. Dermatology. 1994;189(1):65-8.

Ross GL, Orchard DC. Combination topical treatment of molluscumcontagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients. Australas J Dermatol. 2004;45(2):100-2.

Potassium hydroxide 5% for the treatment of molluscumcontagiosum. Drug Ther Bull. 2014;52(10):118-20.

Romiti R, Ribeiro AP, Grinblat BM, Rivitti EA, Romiti N. Treatment of molluscumcontagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol. 1999;16(3):228-31.

Theos AU, Cummins R, Silverberg NB, Paller AS. Effectiveness of imiquimod cream 5% for treating childhood molluscumcontagiosum in a double-blind randomized pilot trial. Cutis. 2004;74(2):134-8, 141-2.

Hanna D, Hatami A, Powell J, Marcoux D, Maari C, Savard P et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscumcontagiosum in children. Pediatr Dermatol. 2006;23(6):574-9.

Srivastava PK, Bajaj AK. Auto wart injection therapy for recalcitrant warts. Indian J Dermatol. 2010;55:367-9.

Nischal KC, Sowmya CS, Swaroop MR, Agrawal DP, Basavaraj HB, Sathyanarayana BD. A novel modification of the auto implantation therapy for the treatment of multiple, recurrent and palmoplantar warts. J Cutan Aesthet Surg. 2012;5:26-9.

Lal NR, Sil A, Gayen T, Bandyopadhyay D, Das NK. Safety and effectiveness of autoinoculation therapy in cutaneous wart: a double-blind,randomized, placebo-controlled study. Indian J Dermatol Venereol Leprol. 2014;80:515-20.

Chandrashekar L. Intralesional immunotherapy for the management of warts. Indian J Dermatol Venereol Leprol. 2011;77:261-3.

Berger EM, Orlow SJ, Patel RR, Schaffer JV. Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: The bump that rashes. Arch Dermatol. 2012;148:1257-64.

Vermi W, Fisogni S, Salogni L, Scharer L, Kutzner H, Sozzani S, et al. Spontaneous regression of highly immunogenic molluscumcontagiosum virus induced skin lesion is associated with plasma cytoid dendritic cells and IFN-DC infiltration. J Invest Dermatol. 2011;131:426-34.

Takematsu H, Tagami H. Pro inflammatory properties of molluscum bodies. Arch Dermatol Res. 1994;287(1):102-6.

Maronn M, Salim C, Lyon C, Galbraith S. One year experience with Candida antigen immunotherapy for wart and molluscum. Pediatr Dermatol. 2008;25(2):189-92.